12.3 C
New York
Friday, April 19, 2024

Credit Suisse Upgrades Laboratory of America To Outperform

Courtesy of Benzinga.

Related LH
Stocks Hitting 52-Week Highs
UPDATE: LabCorp Beats Q4 Expectations, Issues Strong Forecast
Laboratory of America Holdings (LH) CEO Dave King on Q4 2014 Results – Earnings Call Transcript (Seeking Alpha)

Credit Suisse upgraded Laboratory Corp. of America Holdings (NYSE: LH) from Neutral to Outperform.

The price target for Laboratory of America has been raised from $113.00 to $140.00.

Laboratory of America shares have gained 29.14% over the past 52 weeks, while the S&P 500 index has surged 14.22% in the same period.

Laboratory of America’s shares rose 3.36% to close at $121.08 on Friday.

Latest Ratings for LH

Date Firm Action From To
Feb 2015 Piper Jaffray Upgrades Neutral Overweight
Feb 2015 Credit Suisse Upgrades Neutral Outperform
Feb 2015 UBS Downgrades Buy Neutral

View More Analyst Ratings for LH
View the Latest Analyst Ratings

Posted-In: Credit SuisseUpgrades Analyst Ratings

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

157,351FansLike
396,312FollowersFollow
2,290SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x